Literature DB >> 25405920

The development of equine immunity: Current knowledge on immunology in the young horse.

G A Perkins1, B Wagner.   

Abstract

The development of equine immunity from the fetus to adulthood is complex. The foal's immune response and the immune mechanisms that they are equipped with, along with changes over the first months of life until the immune system becomes adult-like, are only partially understood. While several innate immune responses seem to be fully functional from birth, the onset of adaptive immune response is delayed. For some adaptive immune parameters, such as immunoglobin (Ig)G1, IgG3, IgG5 and IgA antibodies, the immune response starts before or at birth and matures within 3 months of life. Other antibody responses, such as IgG4, IgG7 and IgE production, slowly develop within the first year of life until they reach adult levels. Similar differences have been observed for adaptive T cell responses. Interferon-gamma (IFN-γ) production by T helper 1 (Th1)-cells and cytotoxic T cells starts shortly after birth with low level production that gradually increases during the first year of life. In contrast, interleukin-4 (IL-4) produced by Th2-cells is almost undetectable in the first 3 months of life. These findings offer some explanation for the increased susceptibility of foals to certain pathogens such as Rhodococcus equi. The delay in Th-cell development and in particular Th2 immunity during the first months of life also provides an explanation for the reduced responsiveness of young horses to most traditional vaccines. In summary, all immune components of adult horses seem to exist in foals but the orchestrating and regulation of the immune response in immature horses is strikingly different. Young foals are fully competent and can perform certain immune responses but many mechanisms have yet to mature. Additional work is needed to improve our understanding of immunity and immune regulation in young horses, to identify the preferred immune pathways that they are using and ultimately provide new preventive strategies to protect against infectious disease.
© 2015 EVJ Ltd.

Entities:  

Keywords:  antibody; cellular immunity; colostrum; horse: foal

Mesh:

Substances:

Year:  2015        PMID: 25405920     DOI: 10.1111/evj.12387

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  12 in total

Review 1.  Passive transfer of colostral leukocytes: A benefit/risk analysis.

Authors:  John Ellis
Journal:  Can Vet J       Date:  2021-03       Impact factor: 1.008

2.  Neonatal Immunization with a Single IL-4/Antigen Dose Induces Increased Antibody Responses after Challenge Infection with Equine Herpesvirus Type 1 (EHV-1) at Weanling Age.

Authors:  Bettina Wagner; Gillian Perkins; Susanna Babasyan; Heather Freer; Alison Keggan; Laura B Goodman; Amy Glaser; Sigurbjorg Torsteinsdóttir; Vilhjálmur Svansson; Sigríður Björnsdóttir
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

3.  Changes in Blood Lymphocyte Subpopulations and Expression of MHC-II Molecules in Wild Mares Before and After Parturition.

Authors:  Leszek Krakowski; Przemysław Bartoszek; Izabela Krakowska; Anna Stachurska; Tomasz Piech; Piotr Brodzki; Zygmunt Wrona
Journal:  J Vet Res       Date:  2017-12-06       Impact factor: 1.744

4.  The effect of maternal immunity on the equine gammaherpesvirus type 2 and 5 viral load and antibody response.

Authors:  Lilja Thorsteinsdóttir; Sigríður Jónsdóttir; Sara Björk Stefánsdóttir; Valgerður Andrésdóttir; Bettina Wagner; Eliane Marti; Sigurbjörg Torsteinsdóttir; Vilhjálmur Svansson
Journal:  PLoS One       Date:  2019-06-21       Impact factor: 3.240

5.  A novel mechanism for the protection of embryonic stem cell derived tenocytes from inflammatory cytokine interleukin 1 beta.

Authors:  Alyce McClellan; Richard Evans; Cheryl Sze; Shohei Kan; Yasmin Paterson; Deborah Guest
Journal:  Sci Rep       Date:  2019-02-26       Impact factor: 4.379

6.  Composition and Diversity of the Fecal Microbiome and Inferred Fecal Metagenome Does Not Predict Subsequent Pneumonia Caused by Rhodococcus equi in Foals.

Authors:  Canaan M Whitfield-Cargile; Noah D Cohen; Jan Suchodolski; M Keith Chaffin; Cole M McQueen; Carolyn E Arnold; Scot E Dowd; Glenn P Blodgett
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

7.  Acute and chronic infections with nonprimate hepacivirus in young horses.

Authors:  Theresa Gather; Stephanie Walter; Stephanie Pfaender; Daniel Todt; Karsten Feige; Eike Steinmann; Jessika M V Cavalleri
Journal:  Vet Res       Date:  2016-09-22       Impact factor: 3.683

8.  Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equi.

Authors:  Joana N Rocha; Noah D Cohen; Angela I Bordin; Courtney N Brake; Steeve Giguère; Michelle C Coleman; Robert C Alaniz; Sara D Lawhon; Waithaka Mwangi; Suresh D Pillai
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

9.  The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.

Authors:  Christine L Wimer; Christiane L Schnabel; Gillian Perkins; Susanna Babasyan; Heather Freer; Alison E Stout; Alicia Rollins; Nikolaus Osterrieder; Laura B Goodman; Amy Glaser; Bettina Wagner
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

Review 10.  The Veterinary Immunological Toolbox: Past, Present, and Future.

Authors:  Gary Entrican; Joan K Lunney; Sean R Wattegedera; William Mwangi; Jayne C Hope; John A Hammond
Journal:  Front Immunol       Date:  2020-07-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.